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Abstract
 
Nitric oxide (NO) functions as an intercellular messenger
and mediates numerous biological functions. Among the
three isoforms of NO synthase that produce NO, the ubiqui-
tously expressed neuronal NO synthase (nNOS) is responsi-
ble for a large part of NO production, yet its regulation is
poorly understood. Recent reports of two alternative splice-
forms of nNOS in the mouse and in man have raised the
possibility of spatial and temporal modulation of expres-
sion. This study demonstrates the existence of at least three
transcripts of the rat nNOS
 
 
 
gene designated nNOSa, nNOSb,
and nNOSc, respectively, with distinct 5
 
9
 
 untranslated first
exons that arise from alternative splicing to a common sec-
ond exon. Expression of the alternative transcripts occurs
with a high degree of tissue and developmental specificity,
as demonstrated by RNase protection assays on multiple
tissues from both fetal and adult rats. Furthermore, termi-
nal differentiation of rat pheochromocytoma-derived PC12
cells into neurons is associated with induction of nNOSa,
suggesting, likewise, development- and tissue-specific tran-
scriptional control of nNOS isoform expression. Physical
mapping using a rat yeast artificial chromosome clone
shows that the alternatively spliced first exons 1a, 1b, and
1c are separated by at least 15–60 kb from the downstream
coding sequence, with exons 1b and 1c being positioned
within 200 bp of each other.
These findings provide evidence that the biological activ-
ity of nNOS is tightly and specifically regulated by a com-
plex pattern of alternative splicing, indicating that the no-
tion of constitutive expression of this isoform needs to be
revised. (
 
J. Clin. Invest.
 
 1997. 100:1507–1512.) Key words:
nitric oxide
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Introduction
 
Nitric oxide (NO)
 
1
 
 is synthesized by nitric oxide synthase
(NOS) during the NADPH-dependent conversion of 
 
L
 
-argi-
nine to 
 
L
 
-citrulline. Three isoforms of NOS encoded by dis-
tinct genes have been identified. The neuronal and endothelial
NO synthases (nNOS, eNOS) are calcium/calmodulin depen-
dent; their expression has in the past been viewed as constitutive
(1–4). In contrast, the inducible isoform (iNOS) isolated from
macrophages is calcium/calmodulin-independent, and expres-
sion is induced by cytokine stimulation (5, 6). NO is a multi-
functional intercellular messenger affecting diverse aspects of
mammalian physiology including regulation of vascular tone,
macrophage-mediated cytotoxicity, neuronal differentiation,
and synaptic plasticity (7). While the transinteraction of cyto-
kine-responsive elements within the promoter region is thought
to affect the transcriptional regulation of the iNOS gene (8),
the mechanisms by which the ubiquitous expression of the
nNOS gene is regulated are unknown.
The highest expression of nNOS in the rat has been dem-
onstrated in the brain, in particular in the cerebellum. The
gene is also expressed in skeletal muscle, in the myenteric
plexus in the gut, in the macula densa of the kidney, and in the
heart (9, 10). Based on its widespread expression, nNOS is
generally considered to be responsible for the largest propor-
tion of tissue NO synthase activity. Although traditionally la-
beled constitutive, the expression of nNOS may in fact be
tightly regulated, as suggested by a number of recent observa-
tions. nNOS expression was found to be subject to regulation
by estrogen (11), and was induced after axotomy, in parallel
with an increased expression of the transcription factors jun
and krox (12, 13). Furthermore, transient changes in levels of
expression of nNOS have been observed in the developing
rat nervous system and lung (14, 15). Likewise, the onset of
nNOS expression in the developing tectum in chicken coin-
cides with the onset of innervation by axons from retinal gan-
glion cells (16).
Recently, two alternatively spliced nNOS transcripts aris-
ing from two alternative promoters and differing in their
5
 
9
 
-untranslated regions (5
 
9
 
UTR) have been described in hu-
man and murine nNOS genes (17, 18). The use of multiple al-
ternative promoters in conjunction with alternative splicing
may represent a mechanism by which spatial as well as tempo-
ral regulation of nNOS gene transcription is achieved.
Here we present evidence for the presence of three differ-
entially spliced nNOS variants in the rat as well as a compre-
hensive analysis of spatial and temporal expression patterns
that further supports the notion that nNOS expression is mod-
ulated by specific and complex regulatory mechanisms on the
transcriptional level.
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Abbreviations used in this paper:
 
 iNOS, inducible nitric oxide syn-
thase; NGF, nerve growth factor; nNOS, neuronal nitric oxide syn-
thase; NO, nitric oxide; NOS, nitric oxide synthase; RACE, rapid am-
plification of cDNA ends; RT, reverse transcription; UTR, untranslated
regions; YAC, yeast artificial chromosome.
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Methods
 
Rapid amplification of cDNA ends (RACE).
 
Total RNA was ex-
tracted from frozen rat tissues by the guanidium thiocyanate–cesium
chloride gradient method. Genomic DNA was removed by incuba-
tion with RNase-free DNase (Promega Corp., Madison,WI) followed
by phenol/chloroform/isoamyl alcohol (25:24:1) extraction and etha-
nol precipitation. RACE was carried out as previously described (19).
In brief, first-strand cDNA was synthesized from 3 
 
m
 
g total RNA of
various tissues with primer N1 (5
 
9
 
-ggcgtcatctgctcattccgattc-3
 
9
 
) located
at position 211 of the published sequence for the rat nNOS gene (3),
using Superscript II RNase H- Reverse Transcriptase (GIBCO BRL
Life Technologies, Inc., Gaithersburg, MD). The cDNA was column-
purified, tailed with terminal transferase (Life Technologies, Inc.) in
the presence of dCTP (Pharmacia Diagnostics AB, Uppsala, Swe-
den), and then amplified in two sequential rounds of nested PCR in a
25 
 
m
 
l volume, containing 200 nM of each deoxynucleotide triphos-
phate, 2 mM magnesium chloride, 0.1 U Taq polymerase (Promega
Corp.), 75 nM of a poly(G)-anchor primer, and 200 nM of the
gene-specific primers N2 (5
 
9
 
-tgtccccgcccccttccttactct-3
 
9
 
) or N3 (5
 
9
 
-
tcaggggcagcaacgggatgtgtc-3
 
9
 
), respectively. In each reaction, an initial
denaturation for 2 min at 94
 
8
 
C was followed by 35 cycles of 94
 
8
 
C for
30 s, 58
 
8
 
C for 1 min, and 72
 
8
 
C for 2 min and a final extension at 72
 
8
 
C
for 10 min. Amplicons were fractionated on a 2% agarose gel, puri-
fied, and cloned into the PCRII vector using the TA Cloning Kit (In-
vitrogen Corp., San Diego, CA). Clones were sequenced with the Taq
DyeDeoxy Terminator Cycle Sequencing Kit using primer N3 on an
ABI373A automatic sequencer (Applied Biosystems Inc., Foster
City, CA). All newly determined sequences have been deposited with
the GenBank data base (accession numbers: AF008911, AF008912,
AF008913).
 
RNase protection assay.
 
cDNA clones obtained by RACE-PCR
were linearized at appropriate restriction sites at the 5
 
9
 
 end of the in-
sert. Complementary RNAs were transcribed from 1 
 
m
 
g plasmid in
the presence of [
 
a
 
-
 
32
 
P]UTP (DuPont-NEN, Boston, MA) with SP6
RNA polymerase using the MAXIscript kit (Ambion Inc., Austin,
TX). Labeled probes were purified over Chromaspin-100 columns
(Clontech, Palo Alto, CA). RNase protection assay was carried out
using the RPAII kit (Ambion Inc.). In brief, 100,000 cpm of labeled
probe was hybridized against 100 
 
m
 
g total RNA or tRNA overnight
at 45
 
8
 
C. Samples were digested with RNase A and T1, precipitated,
and run on a 5.5% denaturing polyacrylamide gel.
 
Cell culture and reverse transcription PCR (RT-PCR).
 
Differenti-
ation of rat pheochromocytoma–derived PC12 cells into neurons was
carried out as previously described (20). Cells were plated on poly-
 
L
 
-lysine coated dishes in DME supplemented with 10% horse serum
and 5% FCS (Life Technologies, Inc.) at a density of 5 
 
3
 
 10
 
5
 
 cells per
10-cm dish. After 16 h the medium was changed, and 50 ng/ml nerve
growth factor (NGF; Sigma Chemical Co., St. Louis, MO) was added.
Neurite outgrowth development was monitored by light microscopy.
After 9 d cells were washed twice with 1
 
3
 
 PBS, and total RNA was
extracted using the RNeasy kit (QIAGEN Inc., Chatsworth, CA). 3 
 
m
 
g
RNA was reverse transcribed in the presence of 1 
 
m
 
g oligo(dT) and
50 ng random hexanucleotide primers using Superscript II RNase
H- Reverse Transcriptase (Life Technologies, Inc.). PCR was carried
out as described above after validation that under these conditions
PCR product accumulation remained in the exponential phase using
200 nM of each sense and antisense primer. Isoform-specific sense
oligonucleotides for nNOSa (A1 5
 
9
 
-agcgggatccacagccctggaact-3
 
9
 
),
nNOSb (B1 5
 
9
 
-gactgaggggcgacactaccatgc-3
 
9
 
), and nNOSc (C1 5
 
9
 
-cac-
cacagcctctggaatgaaaga-3
 
9
 
), respectively, were combined with the
common antisense primer N1. A cDNA pool derived from brain, em-
bryo, and kidney was included as positive control. To monitor expres-
sion of a housekeeping gene exon spanning oligonucleotides of the
rat 
 
b
 
-
 
actin
 
 gene (ract1 5
 
9
 
-gaccttcaacaccccagccatg-3
 
9
 
; ract2 5
 
9
 
-gggccg-
gactcatcgtactcct-3
 
9
 
) and were used to amplify a 726-bp fragment dur-
ing 25 cycles of PCR (21). Amplicons were fractionated on 2% aga-
rose gels and blotted onto nylon membrane. Southern blot analysis
was performed with the internally located oligonucleotide N3 labeled
with [
 
g
 
-
 
32
 
P]ATP using T4 polynucleotide kinase (New England Bio-
labs Inc., Beverly, MA).
 
Screening of a rat yeast artifical chromosome library.
 
PCR ampli-
fication of screening pools of a rat YAC library (22) was carried out
using oligonucleotide sets specific for the alternative first exons of
nNOSa (Ay1 5
 
9
 
-ggcgctgttggagcccggagca-3
 
9
 
; Ay2 5
 
9
 
-ctgctgccgagc-
ccgcgcagtt-3
 
9
 
), and nNOSb (By1 5
 
9
 
-ccttgagtcgctcggccgcaccat-3
 
9
 
; By2
5
 
9
 
-ggactcctgcgaagccgtcccttg-3
 
9
 
) as well as for the 5
 
9
 
end (5end1 5
 
9
 
-
cgtctgacaagctggtgaccaaga-3
 
9
 
; 5end2 5
 
9
 
-gaacctccagggcactgtcatagc-3
 
9
 
)
and 3
 
9
 
end (3end1 5
 
9
 
-ggctctcacaaaaccgcatcctc-3
 
9
 
; 3end2 5
 
9
 
-aaagagggtg-
gttgggggcttaa-3
 
9
 
) of the published nNOS cDNA sequence. A single
YAC, 228H7, was found that yielded specific amplification products
for all primer sets tested. YAC DNA was isolated from yeast cells
embedded in agarose plugs (22) and digested overnight with each of
the restriction endonucleases 
 
Pac
 
 I, 
 
Pme
 
 I, 
 
Sfi
 
 I, and 
 
Sap
 
 I (New
England Biolabs) or with combinations thereof. Subsequently, plug
DNA was size-fractionated by pulsed field gel electrophoresis in a
1% agarose gel in 0.5
 
3
 
 TBE at 14
 
8
 
C, 6V/cm for 18 h with a switching
time of 15 s and blotted onto nylon membrane. Total rat genomic
DNA was included as control. Southern blot analysis was performed
with probes generated by PCR using the same primers as for the li-
brary screening. Probes were labeled with [
 
a
 
-
 
32
 
P]dCTP (DuPont
NEN) in the presence of random hexamers using T7 DNA poly-
merase (Pharmacia Diagnostics AB).
 
Results
 
Isolation of multiple nNOS transcripts with unique 5
 
9
 
UTRs.
 
Cloning and sequencing of cDNA by RACE from brain, kid-
ney, heart, intestine, and embryo led to the identification of
three different nNOS mRNA species that are designated as
nNOSa, nNOSb, and nNOSc. nNOSa was overall the most
abundant isoform, found especially in the brain, while nNOSb
was almost exclusively expressed in embryonal tissue and
nNOSc in the kidney. A common 3
 
9
 
 terminal sequence consist-
ing of 30 bp was found to be shared by all isoforms extending 5
 
9
 
from position 
 
1
 
2 of the published sequence of the rat nNOS
cDNA (3). Based on PCR analysis of genomic DNA, this 30-bp
common sequence is contiguous with the published 5
 
9
 
 end of
the gene, and therefore represents the actual 5
 
9
 
 end of the sec-
ond exon (previously perceived as the first exon) of the rat
nNOS gene. The unique additional 5
 
9
 
 terminal sequences rep-
resent differential exon 1 sequences of nNOSa, nNOSb and
nNOSc that are spliced to this newly identified 30-bp domain of
the second exon (Fig. 1). The newly identified unique first ex-
ons of nNOSa, nNOSb, and nNOSc are 442, 134, and 151 bp in
length, respectively. RT-PCR with isoform-specific sense and
antisense primers located at various positions of the cDNA as
well as direct sequencing of PCR products yielded no evidence
for additional nNOS mRNA species or further variations
within the coding sequence, except for a previously described
102-bp insert between exon 16 and 17 (23) that was detectable
in skeletal muscle and embryo (data not shown). Comparative
databank searches using the BLAST module showed that
nNOSa shares a high degree of homology with one of the two
alternative first exons identified in the mouse, while neither
nNOSb nor nNOSc showed homology to any of the other alter-
native first exons described in mouse or human (17, 18).
 
Tissue- and development-specific expression of nNOS mRNA-
isoforms.
 
The expression pattern of the different transcrip-
tional variants was determined by RNase protection assay us-
ing cDNA clones obtained by RACE as probes that included
part of the published sequence corresponding to position 
 
1
 
2
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to 
 
1
 
131. Because all three nNOS mRNA isoforms shared the
additional common, newly recognized stretch of 30 bp in exon
2, a 160-bp fragment was expected to be protected, and was in-
deed found to be present in all tissues expressing any of the
nNOS variants. In addition, specific transcript signals corre-
sponding to the 5
 
9
 
 terminus of each nNOSa, nNOSb, and
nNOSc, were found depending on tissue-specific isoform ex-
pression. Consistent with its high prevalence among RACE
clones, nNOSa was the most abundant isoform. It showed
highest expression in brain, followed by kidney, intestine, E18
embryo, adrenal, heart, and skeletal muscle. In contrast,
nNOSb was exclusively expressed in E18 embryo, while
nNOSc expression was found in kidney, skeletal muscle, and
embryo (Fig. 2). Absolute expression levels of nNOSc are low
compared to the other isoforms, and signals were detectable
only after prolonged exposure to autoradiographic material.
The only tissue that consistently tested negative for all three
isoforms of nNOS was the testis.
 
Induction of nNOSa in terminally differentiated PC12
cells.
 
Using sense primers A1, B1, and C1 specific for the al-
ternative first exons in combination with the antisense primer
N1 specific for exon 2 of the rat nNOS gene, RT-PCR followed
by Southern blotting was carried out on cDNA obtained from
rat pheochromocytoma-derived PC12 cells before and after in-
duction of neuronal differentiation by NGF. While nNOS ex-
pression was almost undetectable under basal conditions,
strong induction of nNOSa mRNA was seen in differentiating
cells (Fig. 3).
 
Physical mapping of the alternative first exons of the rat
nNOS gene.
 
PCR analyis using genomic DNA as template
showed that all newly identified 5
 
9
 
UTRs are encoded by a sin-
gle exon, and are not interrupted by intronic sequences. Using
primers anchored in exons 1c and 1b, the two exons were local-
ized at a distance of 150 bp from each other, with exon 1c posi-
tioned upsteam of exon 1b. PCR pools of the rat YAC library
were screened with primer pairs specific for the alternatively
spliced exons (primer pairs Ay1/Ay2 for exon 1a and By1/By2
for exons 1b and 1c), as well as for the 5
 
9
 
 end (exon 2) and 3
 
9
 
end of the published cDNA sequence. A single YAC (1.1 Mb)
was found that gave rise to amplification products from all
primer sets. Restriction mapping using infrequently cutting re-
striction endonucleases positioned exon 1a at a distance of at
Figure 1. Schematic presentation 
of alternative first exons in rat, 
mouse, and human nNOS gene. (A) 
The light grey bar denotes the pub-
lished nNOS cDNA sequence of the 
rat containing the translation initia-
tion site (ATG). A 30-bp extension 
from position 2 (12) of the pub-
lished sequence common to all al-
ternative 59UTRs is indicated by a 
dark grey bar. Unique sequences of 
the alternative 59UTRs are indi-
cated as hatched bar (nNOSa) or 
open bars (nNOSb, nNOSc). A1, 
B1, and C1: sense primer used for 
RT-PCR; N1, N2, and N3: antisense 
primer used for RACE and
RT-PCR. Clones used in RNase 
protection assays included a 160-bp 
stretch common to all nNOS iso-
forms. Alternative 59 sequences of 
the mouse nNOS gene (nNOSb and 
nNOSg;B) and of the human nNOS 
gene (nNOS591 and nNOS592; C). 
Homologous first exons (nNOSa of 
the rat and nNOSb of the mouse) 
are indicated by hatched bars.
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least 15 kb, but of not more than 20 kb upstream of exon 2. Ex-
ons 1b and 1c were placed approximately an additional 40 kb
upstream of exon 1a (Fig. 4).
 
Discussion
 
Our results demonstrate that nNOS in the rat occurs in at least
three isoforms characterized by the presence of different first
exons, and that the previously published information regard-
ing the 5
 
9
 
 end of what we now recognize as exon 2 of the rat
nNOS cDNA was incomplete. In addition, we report that the
three isoforms of the gene show markedly different expression
patterns that are spatially and developmentally distinct. While
the relative abundance of nNOS mRNA in the tissues ana-
lyzed is consistent with previous studies, our findings demon-
strate that overall mRNA levels in some tissues are composed
of different amounts of the mRNA variants of nNOS. Further
studies using in situ hybridization are necessary to elucidate
the spatial and temporal expression of nNOS-mRNA on a tis-
sular and cellular level. These observations suggest a more
complex and intricate pattern of modulation of expression for
this enzyme than previously appreciated, and challenge the
heretofore held perception that nNOS is a constitutively ex-
pressed gene.
The newly identified first exons 1a, 1b, and 1c of the rat
nNOS gene are located upstream of the coding sequence, and
therefore, do not result in a modification of the encoded pro-
tein. Recently, two nNOS mRNAs with alternative 59UTRs
were identified in the mouse as well as in humans (17, 18).
While rat nNOSa shows close homology to one of the mouse
mRNA isoforms (nNOSb), however, no similarity was detect-
able between nNOSb and nNOSc and the second 59UTR
(nNOSg) in the murine nNOS gene. Likewise, no homology
was found between any of the three first exons in the rat and
the two reported alternative exons in humans (nNOS 59 and
nNOS 592). This observation may simply reflect species-spe-
cific differences, or point to the presence of further yet to be
identified alternative 59 ends in the rat that are homologous
with the alternative first exon in mouse and the two human
isoforms, and that may have escaped our present 59RACE
analysis due to low abundance. Although the heterogeneity of
the 59 ends of nNOS mRNA could be explained by alternative
splicing events, it is likely that activation of differential pro-
moters is involved in their generation. In support of this, the
two human nNOS mRNA species are thought to be tran-
scribed from two closely linked, but separable promoters (17).
Figure 2. Analysis of expression by RNase protection assay. Expression patterns of nNOSa (A), nNOSb (B), and nNOSc (C) were examined us-
ing 100 mg total RNA from heart (H), testis (T), adrenal (A), intestine (I), kidney (K), brain (B), skeletal muscle (M), and E18 embryo (E); t, 
tRNA. The sizes of the protected fragments for nNOSa, nNOSb, and nNOSc were 319 bp, 278 bp, and 285 bp, respectively. Pa, Pb, and Pc indi-
cate in vitro–transcribed probes that are 466, 410, and 381 bp, respectively, and included vector-encoded sequence. A protected fragment 160 bp 
in size corresponds to the common sequence shared by all isoforms.
Figure 3. Induction of nNOSa in terminally differentiated PC12 cells. 
RT-PCR of RNA isolated from each of two dishes of PC12 cells with-
out (2NGF) and with NGF treatment (1NGF). Sense primers A1, 
B1, and C1 (specific for nNOSa, nNOSb, and nNOSc, respectively) 
were combined with antisense primer N3 (see Fig. 1), and yielded 
fragment sizes of 202, 208, and 187 bp, respectively. Co1, positive 
control (cDNA pool derived from rat brain, kidney and embryo). 
Co2, negative control (H2O). Actin, 726-bp fragment of the rat
b-actin cDNA.
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Furthermore, the alternative use of multiple first exons
flanked by tissue-specific promoters has been demonstrated
for a number of other genes that are ubiquitously expressed,
such as for the gene encoding aromatase (which, like nNOS, is
a member of the cyotchrome P-450 superfamily) (24) and the
gene encoding the glucocorticoid receptor (24). The hypothe-
sis that expression of nNOSb may be driven by a developmen-
tally regulated promoter is consistent with its transient and ex-
clusive expression during development (14, 15). Our observation
of developmentally specific expression patterns may shed
some light on recent observations obtained in mice carrying a
deletion of exon 2 of the nNOS gene (25). We speculate that
the relative absence of developmental pathology in this model
may be explained by predominance of the still functional tran-
script nNOSb from the first alternative exon, that retains 85%
activity during critical phases of development (18, 25). The
presence of multiple promoters would allow extensive regula-
tion of transcription of a single gene both spatially and tempo-
rally, as suggested by the tissue- and development-specific ex-
pression pattern of nNOS mRNA species presented here.
Reminiscent of the two alternative first exons described in
the human nNOS gene, exons 1c and 1b are located in close
proximity to each other. A pattern search for the sequence jux-
taposed between exons 1c and 1b revealed the presence of a
number of consensus sequences such as those known to inter-
act with nuclear factor-1, AP1, MyoD, GATA, and histoneH4.
Any critical assessment concerning the functional relevance of
these sequence elements and the characterization of putative
promoters, however, must await the results of specific experi-
ments.
Given the broad distribution of nNOS throughout the body
and the extensive spectrum of biological functions mediated by
NO, it would seem likely that the expression of this enzyme is
regulated in a differentiated fashion. The use of alternative
promoters is one mechanism that allows spatial- and temporal-
specific regulation of transcription. The resulting complexity
on the transcriptional level affords the organism the capacity
to respond to numerous signals with a high degree of specific-
ity. Thus, the level of the short-lived molecule NO in any given
tissue is dependent not only on the calcium concentration, but
also on a cell’s specific endowment of trans-acting factors that
control the relative level of expression of each of the known
NO-producing enzymes. The identification of cis- and trans-
acting factors that are responsible for the expression of the
transcriptional variants of the nNOS gene will provide insight
into the molecular mechanisms that control nNOS expression,
and thus into the diversity of functional properties of nNOS in
these tissues.
Increasing evidence suggests a role of 59 and 39UTRs of
mRNAs in the regulation of gene expression. Thus, so-called
iron-responsive elements, found in 59UTRs of genes involved
in iron metabolism control their translational rate in response
to changes of iron levels (26). Certain sequences within the 39-
UTR have been shown to affect mRNA transport and stability
(27), and short open reading frames within 59UTR have been
implicated in the inhibition of translation (28). It is therefore
certainly possible that variations in length or sequence of the
59UTRs of the rat nNOS mRNA isoforms may affect nNOS
protein levels via different posttranscriptional mechanisms.
NO has an extremely wide spectrum of functional proper-
ties that is unprecedented in biology. As one of the smallest
water- and lipid- soluble carriers capable of chaperoning a free
electron within and between cells, NO has access to a number
of molecules, and is able to modify the state of active sites. It
has been implicated in the regulation of ion channels, GTPases,
and transcription factors (29–31). To fulfill these multiple
roles, a regulated mode of expression of nNOS, as supported
by our findings, would appear reasonable, and, indeed perhaps
essential.
Our observation of developmentally specific expression
patterns of nNOS isoforms is compatible with emerging evi-
dence that NO is involved in developmental processes such as
apoptosis and differentiation. NO has been shown to trigger
the switch to growth arrest during differentiation of PC12 cells
into neuronal cells in response to NGF, a phenomenon that is
accompanied by an induction of both calcium-independent
and calcium-dependent NOS acitivity (20). Likewise, NO has
been implicated as conferring antiproliferative effects during
Figure 4. Physical mapping of the rat nNOS gene by pulsed-field gel 
electrophoresis. (A) Restriction map of YAC 228H7 with infre-
quently cutting restriction endonucleases and relative position of 
probes for exon 1a, 1b, and 1c. (B) Sequences for the three alterna-
tive exons as well as for the newly identified 59 end of exon 2 are de-
picted in capital letters. Lower case letters denote the intervening se-
quence between exon 1c and 1b. (C) Schematic presentation of the 
splicing pattern of the alternative 59UTRs of the rat nNOS gene. 
Drawings are not to scale.
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Drosophila development, controlling the balance between cell
proliferation and cell differentiation (32). Although the rele-
vant NOS isozyme has not been specifically identified, dNOS,
the only NOS-encoding gene cloned from Drosophila to date,
shows strong homology to the mammalian nNOS (33). Our
finding that differentiation of PC12 cells into neurons is ac-
companied by the induction of nNOSa, the most abundant
nNOS transcript found in the mature brain, is consistent with
this proposed growth- or differentiation-regulating role of
nNOS. In addition, since transcriptional activation of specific
promoter elements by NGF in PC12 cells has been demon-
strated for a number of genes, such as the genes encoding neu-
ropeptide Y gene and transforming growth factor-beta gene
(34, 35), it seems reasonable to speculate that a similar mecha-
nism may account for the specific induction of nNOSa.
In summary, we report original evidence that differential
transcripts of nNOS show tissue- and development-specific ex-
pression patterns, and propose that this may represent a here-
tofore unrecognized mechanism of regulatory modulation of
nNOS expression.
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